CVS Pharmacy announced on Saturday that it had discontinued the sale of all Zantac and CVS Health-ranitidine products until further notice. and cause cancer.
Although Zantac and ranitidine products have not been downloaded and the FDA does not recommend that patients stop taking these products, clients can still return the products to CVS for reimbursement.
Ranitidine is an H2 blocker that
CVS says will continue to sell other non-prescription H2 blockers, including Pepcid, Tagamet and other equivalents.
